Argentina acts on counterfeit erectile dysfunction devices - "some imported legally":
This article was originally published in Clinica
Executive Summary
Argentina's medical products regulatory agency, ANMAT, has issued an alert regarding the discovery of counterfeit erectile dysfunction devices on the market. The agency reports that some of the devices involved were manufactured locally, but that others appear to have been imported legally, even though they were not registered, exposing a possible weakness in import controls. It has thus raised the issue with the Customs agency. The COMFER consumer protection agency has also been alerted, since the products are being marketed with "therapeutic claims that have no scientific basis", while lacking warnings regarding risks and the need for medical supervision.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.